These highlights do not include all the information needed to use UZEDY™ safely and effectively. See full prescribing information for UZEDY. UZEDY ( risperidone) extended-release injectable suspension, for subcutaneous use Initial U.S. Approval:
Teva's long-acting schizophrenia drug rejected by FDA | pharmaphorum
LAI for Schizophrenia | Features of UZEDY™ (risperidone) extended-release injectable suspension
Dosing & PK Data | UZEDY™ (risperidone) extended-release injectable suspension
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
Teva Moves Forward With LAI Olanzapine Trials :: Generics Bulletin
UZEDY™ (risperidone) extended-release injectable suspension | Official Patient Site | Now Approved
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults
RISPERIDONE TEVA 2 MG COMP 100 | Apotheek Claeys
Köp Risperidone Teva GmbH Pulver och vätska till injektionsvätska, depotsuspension 37,5 mg Risperidon 1 styck på Kronans Apotek | Kronans Apotek
Risperidone "Teva GmbH" Teva GmbH pulver og solvens til depotinjektionsvæske, suspension 25 mg, 37,5 mg og 50 mg
Teva Upbeat On Risperidone Results :: Generics Bulletin
Teva Risperidone comprimé 4mg | Jean Coutu
FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults-CliniExpert